To evaluate the effectiveness and tolerance of the AdVance Male Sling System for the treatment of male stress urinary incontinence in patients after prostatic surgery.
An international, observational, prospective, multicenter study was conducted on male patients with urinary incontinence after prostatic surgery. Patients underwent a 24-hour pad test with a threshold at 250 g. All patients were operated with the same AdVance implant procedure. They were seen 6 weeks later, and examined again at 3, 6, 12, and 24 months. Incontinence was measured using 1-hour and 24-hour pad tests, the number of protective pads used, ICIQ-SF and IQoL questionnaires. Success was defined as no urinary leakage and no pad use. Patient improvement was defined as a reduction of more than 50% in leakage and no more than one pad used per day. Any perioperative and late complications were documented.
From January 2007 to November 2012, 113 patients were successfully operated on. At 24 months after surgery, the mean weight of the 1-hour pad test had decreased from 48.7 g to 6.6 g (P < 0.001) while that of the 24-hour pad test decreased to 45.0 g from 113.9 g (P < 0.001). Success and improvement occurred in 22.6% and 58.0% of the patients, respectively. Seventy-five patients (80.6%) used none or one protective pad daily, and the IQoL and ICIQ-SF scores were both significantly improved. Fourteen patients (12.4%) required a second intervention. Three patients (2.7%) had a Clavien IIIb complication.
The AdVance Male Sling System is an effective treatment for mild to moderate male stress urinary incontinence. Complications from its use are rare and 24-month results are satisfactory.
Urology. 2018 Jul 02 [Epub]
Haixia Ye, François Haab, Dirk de Ridder, Philippe Chauveau, Armin Becker, Pedro Arano, Olivier Haillot, Hakim Fassi-Fehri
Edouard Herriot Hospital, Lyon, France. Electronic address: ., Institution Tenon Hospital, Paris, France., UZ Gasthuisberg, Leuven, Belgium., Clinique Jules Verne, Nantes, France., Ludwig-Maximilians-University, München, München, Germany., Fundacion Puigvert, Barcelona, Spain., Hospital Bretonneau, Tours, France., Edouard Herriot Hospital, Lyon, France.